ARCHIVES

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

This article is from The Cancer Letter archive.

Vol. 11 No. 30 | July 26, 1985

Download PDF Visit The Full Archive

Related Articles

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

Letter to the Editor

February 21, 2003